Biora Therapeutics Total Liabilities

Biora Therapeutics (BIOR) currently reports a total liabilities of $120M as of September 2024. That compares with $150M in the prior-year period — down 21.1% year over year. Use the charts on this page to explore Biora Therapeutics's total liabilities history and peer comparisons.

Biora Therapeutics's total liabilities decreased from $150M to $120M — a 21.1% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biora Therapeutics reported $120M in total liabilities as of September 2024. That compares with $150M in the prior-year period — down 21.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biora Therapeutics, and consider following BIOR for alerts when major investors trade the stock.

Biora Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIOR with unrelated industries.